Vinorelbine
2 NDCs across 1 manufacturer|2 Generic,0 Brand
Vinorelbine is used to treat breast neoplasms, non-small-cell lung carcinoma, hodgkin disease and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Vinorelbine is available as 2 NDCs from 1 manufacturer (2 generic, 0 brand), with NADAC prices from $17.06 to $18.96 per ML — a 11% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
1
competing in market
Price Spread
$17.06 – $18.96
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing VINORELBINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VINORELBINE 10 MG/ML VIAL | $18.9617 per ML | — |
VINORELBINE 50 MG/5 ML VIAL | $17.0583 per ML | — |
Frequently Asked Questions
What is Vinorelbine used to treat?
Vinorelbine is used to treat breast neoplasms, non-small-cell lung carcinoma, hodgkin disease and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.
How many Vinorelbine products are on the market?
The Vinorelbine drug market contains 2 NDCs from 1 manufacturer — 2 generic and 0 brand products.
What is the price range for Vinorelbine?
NADAC reference prices for Vinorelbine range from $17.0583 to $18.9617 per ML — a 11% difference between cheapest and most expensive.
Which manufacturers make Vinorelbine?
1 manufacturer lists Vinorelbine in NADAC. Ranked by number of NDCs, the largest are Sagent Pharmaceuticals (2).